Summary
For Year 2026-27, Torrent Pharmaceuticals reports the following shareholding: Total Promoters at 68.31%, Mutual Fund at 4.45%, Insurance at 1.94%, Foreign Institutional Investors at 16.18%, Domestic Institutional Investors at 2.67%, and Retail at 6.45%. This breakdown provides a quick snapshot of ownership distribution for Torrent Pharmaceuticals in 2026-27.
Torrent Pharmaceuticals FAQs
As of 04-2026, the promoter shareholding in Torrent Pharmaceuticals stands at 68.31% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Torrent Pharmaceuticals is 16.18% and 2.67% respectively.
The retail shareholding of the Torrent Pharmaceuticals is 6.45%.
Changes in shareholding patterns of Torrent Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Torrent Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Torrent Pharmaceuticals Associated Pages
- Torrent Pharmaceuticals Share Price
- Torrent Pharmaceuticals Share Price chart
- Torrent Pharmaceuticals Fundamental Analysis
- Torrent Pharmaceuticals Technical Analysis
- Torrent Pharmaceuticals Peer Comparison
- Torrent Pharmaceuticals Share Price History
- Torrent Pharmaceuticals Dividend
- Torrent Pharmaceuticals Board of Directors
